Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.62 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.62 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | CES2 | O00748 | 1/20 | 0.54 |
| ▸ | CES1 | P23141 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL69614 | 0.87 | CA2 (0.79) | CA2CAMK2AAKR1B1TSHRLMNA | |
| Hydrochloric Acid SCHEMBL25180348 | 0.84 | CA2 (0.75) | CA2CAMK2AAKR1B1TSHRLMNA | |
| Hydrochloric Acid SCHEMBL6765874 | 0.84 | CA2 (0.75) | CA2CAMK2AAKR1B1TSHRLMNA | |
| SCHEMBL6502081 | 0.81 | ALDH1A1 (0.59) | CA2CAMK2AAKR1B1TSHRLMNA | |
| SCHEMBL6596642 | 0.80 | CES2 (0.48) | CA2CAMK2AAKR1B1TSHRLMNA | |
| SCHEMBL29257 | 0.80 | MEN1 (0.71) | CA2CAMK2AAKR1B1TSHRLMNA | |
| SCHEMBL68027 | 0.79 | LMNA (0.86) | CA2CAMK2AAKR1B1TSHRLMNA | |
| SCHEMBL2996429 | 0.79 | CA2 (0.68) | CA2CAMK2AAKR1B1TSHRLMNA | |
| SCHEMBL18427891 | 0.79 | LMNA (0.86) | CA2CAMK2AAKR1B1TSHRLMNA | |
| SCHEMBL3787817 | 0.78 | MEN1 (0.69) | CA2CAMK2AAKR1B1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115536517-B | Preparation method of 4-hydroxymethylphenylacetic acid | 苏州昊帆生物股份有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-118065175-A | Method for constructing paper superhydrophobic surface by using hemicellulose as nanoparticle adsorbent | 华南理工大学 | 2024-05-24 | — | — | CN | claimed |
| CN-115536517-A | Preparation method of 4-hydroxymethyl phenylacetic acid | 苏州昊帆生物股份有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-111517997-B | Ethyl sulfate artificial antigen, preparation method and application | 杭州博拓生物科技股份有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-108478817-B | Atherosclerosis detection reagent and preparation method thereof | 北京大学 | 2020-10-27 | — | — | CN | claimed |
| CN-111517997-A | Ethyl sulfate artificial antigen, preparation method and application | 杭州博拓生物科技股份有限公司 | 2020-08-11 | — | — | CN | claimed |
| CN-105153145-B | Aryl piperazine derivative II and its salt, preparation method and purposes | 广州市广金投资管理有限公司 | 2018-10-30 | — | — | CN | claimed |
| CN-105130921-B | Aryl piperazine derivative I and its salt, preparation method and purposes | 广州市广金投资管理有限公司 | 2018-04-06 | — | — | CN | claimed |
| CN-105503747-B | A kind of quinazoline derivant LU1507 and its preparation method and application | 中国人民解放军南京军区南京总医院 | 2017-12-19 | — | — | CN | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| WO-2003011917-A1 | METHOD OF CURING ELASTOMERS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2003-02-13 | — | — | WO | claimed |
| EP-1124417-A2 | COMPOSITIONS COMPRISING PLANT CELL GROWTH REGULATING COMPOUNDS AND METHODS OF USE THEREOF | INVITROGEN CORPORATION (US) | 2001-08-22 | — | — | EP | claimed |
| WO-2000024249-A2 | COMPOSITIONS COMPRISING PLANT CELL GROWTH REGULATING COMPOUNDS AND METHODS OF USE THEREOF | INVITROGEN CORPORATION (US) | 2000-05-04 | — | — | WO | claimed |
| EP-0433345-A1 | PEPTIDE SYNTHESIS METHOD AND SOLID SUPPORT FOR USE IN THE METHOD. | RISOE FORSKNINGSCENTER (DK) | 1991-06-26 | — | — | EP | claimed |
| WO-1990002749-A1 | PEPTIDE SYNTHESIS METHOD AND SOLID SUPPORT FOR USE IN THE METHOD | Forskningscenter Risø (DK) | 1990-03-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | CA2 32/4885CAMK2A 1756/4885AKR1B1 1963/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | CA2 664/4885CAMK2A 2997/4885AKR1B1 2784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.